2021 Investor Day

ResMed device market share Q3FY14 Q4FY14 Q1FY15 Q2FY15 Q3FY15 Q4FY15 1Estimate prior to competitor recall Shift to digitally-enabled treatment has fueled growth Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Device market share compared to AirView and myAir growth Q3FY17 Q4FY17 Q1FY18 AirView Q2FY18 Q3FY18 myAir Q4FY18 Q1FY19 Q2FY19 ResMed Q3FY19 Q4FY19 Q1FY20 Q2FY20 Q3FY20 Q4FY20 Q1FY21 Q2FY21 Q3FY21 Q4FY21 16.5M+ AirView and myAir growth 3.5M+ Launches of new, digitally-enabled products have driven market growth, and increased patient adherence and market share gains Demonstrates ability to drive market growth with unique and innovative solutions Over time, we have shifted toward a tech-focused strategy vs. device-focused; future product launches to be driven by digital health © 2021 ResMed | 2021 Investor Day - Sept 8, 2021 #1 market share1 in sleep apnea devices and masks 35

View entire presentation